Circ Heart Fail Approach to Acute Cardiovascular Complications in COVID-19 Infection

[tetano]

irc Heart Fail


. 2020 Jun 5.
doi: 10.1161/CIRCHEARTFAILURE.120.007220. Online ahead of print.
Approach to Acute Cardiovascular Complications in COVID-19 Infection


Lauren S Ranard ¹ , Justin A Fried ¹ , Marwah Abdalla ¹ , D Edmund Anstey ¹ , Raymond C Givens ¹ , Deepa Kumaraiah ¹ , Susheel K Kodali ² , Koji Takeda ³ , Dimitri Karmpaliotis ² , LeRoy E Rabbani ¹ , Gabriel Sayer ¹ , Ajay J Kirtane ⁴ , Martin B Leon ² , Allan Schwartz ¹ , Nir Uriel ¹ , Amirali Masoumi ¹



Affiliations

• PMID: 32500721
• DOI: 10.1161/CIRCHEARTFAILURE.120.007220

Abstract

The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic. It has spread to more than 187 countries with a rapidly growing number of affected patients. Underlying cardiovascular disease is associated with more severe manifestations of COVID-19 and higher rates of mortality. COVID-19 can have both primary (arrhythmias, myocardial infarction, myocarditis) and secondary (myocardial injury/biomarker elevation, heart failure) cardiac involvement. In severe cases, profound circulatory failure can result. This review discusses the presentation and management of patients with severe cardiac complications of COVID-19 disease, with an emphasis on a "Heart-Lung" team approach in patient management. Furthermore, it focuses on the use of and indications for acute mechanical circulatory support in cardiogenic and/or mixed shock.